Quantum Labs
繁體中文
PT-141 10 mg10 瓶組庫存 6省 25%
peptideintermediate庫存 6

PT-141 10 mg

Bremelanotide 黑皮質素促效劑

PT-141 bremelanotide research peptide, Australian-shipped. Lab-verified ≥99% purity.

劑量
10mg / 瓶
劑型
凍乾粉末
包裝
10 瓶組

僅供研究使用。 本化合物嚴格用於體外研究及實驗室用途,不得供人體食用或治療用途。購買即確認您為合格研究者,並同意我們的 完整免責聲明。

$4,434 TWD
省 25%
10 瓶組
原價 $5,912 TWD
以 10 瓶組出售

只剩 6 組

🧪實驗室驗證
✓第三方檢測
⚡全球快速運送
🔒安全信用卡付款
概覽

合成黑皮質素受體促效劑,文獻關注其對與性反應相關神經路徑的影響(研究應用)。

PT-141 (bremelanotide) is a synthetic melanocortin-receptor agonist derived from the alpha-melanocyte-stimulating hormone (α-MSH) family. It is one of the most studied melanocortin-pathway research peptides outside of the tanning-active analogues. Quantum Labs supplies PT-141 as a lyophilised powder for Australian research applications.

Research on PT-141 has covered the central melanocortin pathway, particularly MC3R and MC4R receptor activation, and pre-clinical models of sexual-response signalling. Material is HPLC-verified to ≥99% purity and ships from Australian stock; supplied for laboratory research use only.

作用機制

研究顯示其主要促效 MC4R,並對研究對象中樞神經系統的神經化學指標產生影響。

實驗室報告

經 HPLC 驗證,純度規格 ≥99%。由獲認可的第三方實驗室獨立檢測。

研究者常见問題

PT-141 — 常见問題

What is PT-141?

PT-141 (bremelanotide) is a synthetic melanocortin-receptor agonist studied in research models of central melanocortin-pathway signalling. It is one of the most-studied research peptides in the melanocortin family alongside the tanning-active analogues.

Is PT-141 legal in Australia?

PT-141 is restricted for compounded human therapeutic supply in Australia and remains available for research and laboratory use when supplied without therapeutic representation. Quantum Labs supplies PT-141 for research use only.

What receptors does PT-141 target?

PT-141 primarily activates the melanocortin-3 (MC3R) and melanocortin-4 (MC4R) receptors. Research has focused on the central melanocortin pathway, particularly downstream signalling in MC4R-rich brain regions.

What is bremelanotide?

Bremelanotide is the generic name for PT-141. It is a cyclic synthetic peptide derived from the α-MSH lineage. PT-141 is the research-code designation; bremelanotide is the pharmaceutical name.

What is the typical PT-141 research dosage?

Published research protocols have used wide dose ranges depending on the model and delivery route (intranasal, subcutaneous). Human dosing is not established. Researchers should consult primary literature for protocol-specific guidance.

延伸阅讀

與 PT-141 相關的指南

相關化合物

研究者還會瀏覽